{"transactions":[{"id":693642,"issuer":{"id":6419,"kind":"organization","name":"Waldencast plc"},"owners":[{"id":25618,"kind":"person","name":"Manfredi Manuel","position":1,"cik":"0002110736","reported_name":"Manfredi Manuel","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Restricted Stock Units","published_at":"2026-08-07T20:10:23.000Z","date":"2026-07-30","kind":"exercise","planned":false,"acquired":false,"shares":79289,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each RSU represents a contingent right to receive one Class A ordinary share, or an equivalent value in cash at the plan administrator's election."},{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents accelerated vesting of 79,289 outstanding restricted stock units (\"RSUs\") held by the reporting person in connection with the completion of the Issuer's sale of its Obagi Medical dermatological skincare and aesthetics business on July 30, 2026. Effective on the date of completion of such sale, the reporting person transitioned from the Issuer to lead Obagi Medical."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"On October 30, 2024, the reporting person was granted 118,933 RSUs, which would have vested over a three-year period as follows: (i) 39,644 on October 1, 2025; (ii) 39,644 on October 1, 2026; and (iii) 39,645 on October 1, 2027."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"On October 30, 2024, the reporting person was granted 118,933 RSUs, which would have vested over a three-year period as follows: (i) 39,644 on October 1, 2025; (ii) 39,644 on October 1, 2026; and (iii) 39,645 on October 1, 2027."}],"balance_after":0,"derivative":{"underlying":"Class A Ordinary Shares","underlying_shares":79289},"source":{"system":"sec-edgar","filing":"0001840199-26-000091","document":"wk-form4_1786133421.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1840199/000184019926000091/wk-form4_1786133421.xml","form_type":"4"}},{"id":693641,"issuer":{"id":6419,"kind":"organization","name":"Waldencast plc"},"owners":[{"id":25618,"kind":"person","name":"Manfredi Manuel","position":1,"cik":"0002110736","reported_name":"Manfredi Manuel","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Class A Ordinary Shares","published_at":"2026-08-07T20:10:23.000Z","date":"2026-07-30","kind":"exercise","planned":false,"acquired":true,"shares":79289,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents accelerated vesting of 79,289 outstanding restricted stock units (\"RSUs\") held by the reporting person in connection with the completion of the Issuer's sale of its Obagi Medical dermatological skincare and aesthetics business on July 30, 2026. Effective on the date of completion of such sale, the reporting person transitioned from the Issuer to lead Obagi Medical."}],"balance_after":118933,"source":{"system":"sec-edgar","filing":"0001840199-26-000091","document":"wk-form4_1786133421.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1840199/000184019926000091/wk-form4_1786133421.xml","form_type":"4"}}]}